Also interesting
![Download](https://www.kickstartbiomanufacturing.be/assets/uploads/site/pdc-line-is-shaping-the-future-of-the-lung-cancer-vaccine/_767x490_crop_center-center_95_none/download.jpeg)
PDC*Line is shaping the future of the lung cancer vaccine
PDC*line targets advanced, metastatic and non-operable cancers in the first line of treatment, in combination with an existing anti-cancer therapy.
![Takeda announcement investment LR](https://www.kickstartbiomanufacturing.be/assets/uploads/site/takeda-invests-close-to-300-million-euros-in-its-plasma-derived-therapies-production-site-in-lessines/_767x490_crop_center-center_95_none/Takeda-announcement-investment_LR.jpg)
Takeda Invests Close to 300 Million Euros in its Plasma-Derived Therapies Production Site in Lessines
The investment encompasses a new production facility and a carbon net-zero emissions warehouse.
![Quantoom Biosciences Kickstart](https://www.kickstartbiomanufacturing.be/assets/uploads/site/making-mrna-vaccine-production-in-africa-a-reality/_767x490_crop_center-center_95_none/Quantoom-Biosciences_Kickstart.png)
Making mRNA vaccine production in Africa a reality
Together with Afrigen Biologics, Quantoom Biosciences is paving the way for African mRNA vaccine production with its Ntensify™ Midi system.